Cordlife Group Limited
Dang Vinh Do is a Laboratory Director with extensive experience in research and science. They have held various roles in reputable companies such as Cordlife Medical Phils, Inc., Cordlife Indonesia, and Cordlife Group Limited. Their educational background includes a PhD in Biochemistry from the National University of Singapore, where they also completed an MSc and BSc in related fields. Their research interests primarily focus on the role of STAT3 in stem cell pluripotency.
This person is not in any offices
Cordlife Group Limited
Cordlife owns the largest network of cord blood banks in Asia with full stem cell banking facilities in six key markets, namely Singapore, Hong Kong, Indonesia, India, Malaysia and the Philippines. In Singapore, Hong Kong, the Philippines and Indonesia, Cordlife operates the largest private cord blood banks and it is amongst the top three market leaders in India and Malaysia. In January 2018, Cordlife became the market leader in Hong Kong with the acquisition of the largest private cord blood bank, Healthbaby Biotech (Hong Kong) Co., Limited. Through its majority-owned subsidiary in Malaysia, Stemlife Berhad, Cordlife holds an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife has also established its presence in Myanmar, Vietnam, Macau, Brunei and Bangladesh.